Parkinson’s Disease – INT-001

The objective of this clinical trial is to explore the analgesic effect of intradermal needle therapy on patients after gastric endoscopic submucosal dissection； analyze factors related to postoperative pain in gastric endoscopic submucosal dissection (ESD) patients, and evaluate the safety of intradermal needle therapy.

Inclusion Criteria:

1. Meet the surgical indications for gastric endoscopic submucosal dissection;
2. All patients signed a written “Surgical Consent Form” before surgery;
3. Complete clinical data;
4. Informed consent and participation in this study.
5. Other criteria may apply

Complete the form and our team will reach out soon to help determine your eligibility.